Soltan Dallal Mohammad Mehdi, Yazdi Mohammad Hossein, Holakuyee Marzieh, Hassan Zuhair Mohammad, Abolhassani Mohsen, Mahdavi Mehdi
Department of Pharmaceutical Biotechnology, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Allergy Asthma Immunol. 2012 Jun;11(2):183-9.
Lactic acid bacteria which are used as probiotics have ability to modulate immune responses and modify immune mechanisms. It has also been indicated that some strains of this family can affect the immune responses against solid tumors. In the present work, we proposed to study the effects of oral administration of L.cacesi ssp casei on the NK cells cytotoxicity and also production of cytokines in spleen cells culture of BALB/c mice bearing invasive ductal carcinoma. 30 female In-bred BALB/c mice, were used and divided in two groups of test and control each containing 15 mice. Every day from 2 weeks before tumor transplantation 0.5 ml of PBS containing 2.7×108 CFU/ml of L.casei spp casei was orally administered to the test mice and it was followed 3 weeks after transplantation as well with 3 days interval between each week. Control mice received an equal volume of PBS in a same manner. Results showed that oral administration of L. casei significantly increased the production of IL-12 and IFN-γ (P<0.05) and increased the natural killer cells (NK) cytotoxicity in spleen cells culture of test mice (P<0.05). It has also been demonstrated that the growth rate of tumor in the test mice was decreased and their survival was significantly prolonged in comparison to the controls. Our findings suggest that daily intake of L.casei can improve immune responses in mice bearing invasive ductal carcinoma, but further studies are needed to investigate the other involving mechanisms in this case.
用作益生菌的乳酸菌具有调节免疫反应和改变免疫机制的能力。也有研究表明,该菌属的一些菌株可影响针对实体瘤的免疫反应。在本研究中,我们旨在探讨口服干酪乳杆菌干酪亚种对荷浸润性导管癌的BALB/c小鼠脾脏细胞培养中自然杀伤细胞(NK)细胞毒性及细胞因子产生的影响。选用30只雌性近交BALB/c小鼠,分为试验组和对照组,每组15只。从肿瘤移植前2周开始,每天给试验组小鼠口服0.5 ml含2.7×108 CFU/ml干酪乳杆菌干酪亚种的磷酸盐缓冲液(PBS),移植后3周继续给药,每周给药3次,间隔3天。对照组小鼠以同样方式接受等量PBS。结果显示,口服干酪乳杆菌显著增加了试验组小鼠脾脏细胞培养中白细胞介素-12(IL-12)和干扰素-γ(IFN-γ)的产生(P<0.05),并增加了自然杀伤细胞(NK)的细胞毒性(P<0.05)。此外还证明,与对照组相比,试验组小鼠肿瘤生长速度降低,生存期显著延长。我们的研究结果表明,每日摄入干酪乳杆菌可改善荷浸润性导管癌小鼠的免疫反应,但在此情况下还需要进一步研究以探究其他相关机制。